Silvant Capital Management LLC Takes $102,000 Position in Healthpeak Properties, Inc. (NYSE:DOC)

Silvant Capital Management LLC bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,479 shares of the real estate investment trust’s stock, valued at approximately $102,000.

Other institutional investors have also modified their holdings of the company. HM Payson & Co. purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $25,000. S.A. Mason LLC purchased a new stake in Healthpeak Properties during the third quarter worth about $26,000. Rise Advisors LLC purchased a new stake in Healthpeak Properties during the third quarter worth about $29,000. Fortitude Family Office LLC purchased a new stake in shares of Healthpeak Properties in the third quarter valued at about $32,000. Finally, Barrett & Company Inc. purchased a new stake in shares of Healthpeak Properties in the third quarter valued at about $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of DOC stock opened at $21.98 on Friday. Healthpeak Properties, Inc. has a 52 week low of $15.44 and a 52 week high of $23.26. The stock’s fifty day moving average is $22.30 and its 200-day moving average is $20.81. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.70 and a current ratio of 1.31. The stock has a market capitalization of $15.37 billion, a PE ratio of 46.77, a PEG ratio of 2.50 and a beta of 1.13.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. During the same period in the prior year, the firm posted $0.45 EPS. Healthpeak Properties’s revenue was up 25.9% on a year-over-year basis. Equities research analysts expect that Healthpeak Properties, Inc. will post 1.8 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a $0.30 dividend. The ex-dividend date is Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a yield of 5.46%. Healthpeak Properties’s payout ratio is 255.32%.

Analyst Ratings Changes

DOC has been the subject of a number of analyst reports. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday. Robert W. Baird upped their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research note on Wednesday. Wedbush upped their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Citigroup increased their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Finally, Royal Bank of Canada increased their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $22.79.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.